Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride improves hidradenitis suppurativa but not for child-bearing women.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

Estrogen therapy helped regrow hair in a bald man.

JAK inhibitors help hair regrowth in alopecia areata but have a high risk of side effects.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

In Denmark from 1995 to 2016, hospital-treated alopecia areata cases increased, mostly affecting women and those over 50.

Methotrexate and vitamin D3 are potentially more effective and safer than triamcinolone for treating localized alopecia areata.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Oxidative stress is linked to mild patchy alopecia areata.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Patients with oral lichen planus or oral lichenoid reactions had worse cholesterol levels and a higher risk of obesity compared to healthy individuals.

Adolescents with severe alopecia incur significantly higher healthcare costs.

Alopecia areata in US adolescents leads to significant healthcare costs and usage.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

Insulin resistance may contribute to hair loss in people with androgenic alopecia.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

Turkish pregnant women commonly experienced skin issues like itching and acne, and doctors mainly used topical treatments due to safety concerns during pregnancy.

Melatonin may benefit skin health and could be a promising treatment in dermatology.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Stem cells help repair tissue mainly by releasing beneficial substances, not by replacing damaged cells.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Surface Plasmon Resonance is a useful tool for studying protein interactions and has potential for future technological advancements.

Eyelashes protect the eyes, but more research is needed to understand how.